Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Dificid Fidaxomicin 200mg Film coated tablet Merck Sharp & Dohme (New Zealand) Limited Patheon Inc, Ontario, Canada
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Opdivo Nivolumab 47mg equivalent to 40mg/4mL Concentrate for infusion Bristol-Myers Squibb (NZ) Limited Bristol-Myers Squibb Holdings Pharma Limited, Manati, Puerto Rico
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Opdivo Nivolumab 107mg equivalent to 100mg/10mL Concentrate for infusion Bristol-Myers Squibb (NZ) Limited Bristol-Myers Squibb Holdings Pharma Limited, Manati, Puerto Rico
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Sandomigran Pizotifen malate 0.725mg equivalent to Pizotifen 0.5mg Tablet AFT Pharmaceuticals Limited Labiana Pharmaceuticals SL, Barcelona, Spain
|
Product: Active Ingredients:
Dosage Form: New Zealand Sponsor: Manufacturer:
|
Soothers - Honey and Lemon Eucalyptus oil 0.7mg Menthol 7mg Sodium ascorbate 11.25mg equivalent to 10mg ascorbic acid Lozenge Nestle New Zealand Limited Nestle Australia Limited, Blacktown, Australia
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Winglore (50mg/10mL) Ipilimumab 5mg/mL Concentrate for injection Bristol-Myers Squibb (NZ) Limited Baxter Pharmaceutical Solutions LLC, Bloomington, United States of America Bristol-Myers Squibb Holdings Pharma Limited, Manati, Puerto Rico
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Winglore (200mg/40mL) Ipilimumab 5mg/mL Concentrate for injection Bristol-Myers Squibb (NZ) Limited Baxter Pharmaceutical Solutions LLC, Bloomington, United States of America Bristol-Myers Squibb Holdings Pharma Limited, Manati, Puerto Rico
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Yervoy (50mg/10mL) Ipilimumab 5mg/mL Concentrate for injection Bristol-Myers Squibb (NZ) Limited Baxter Pharmaceutical Solutions LLC, Bloomington, United States of America Bristol-Myers Squibb Holdings Pharma Limited, Manati, Puerto Rico
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Yervoy (200mg/40mL) Ipilimumab 5mg/mL Concentrate for injection Bristol-Myers Squibb (NZ) Limited Baxter Pharmaceutical Solutions LLC, Bloomington, United States of America Bristol-Myers Squibb Holdings Pharma Limited, Manati, Puerto Rico
|
Dated this 3rd day of May 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).